Sight Sciences nabs $10 mln Series C

Menlo Park, California-based Sight Sciences Inc, an ophthalmic medical device company, has raised $10 million in Series C financing. Allegro Investment Fund led the round.

9 October 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail